Similar Papers

Paper Title
Journal
Date
Author
Proton Pump Inhibitors Associated with Higher Incidence of Mucositis in Patients Receiving Methotrexate for Graft Vs Host Disease Prophylaxis
Luke Mountjoy ... Daniel Almquist
Biology of Blood and Marrow Transplantation | VOL. 26
Luke Mountjoy, et. al.Luke Mountjoy ... Daniel Almquist
23 Jan 2020
Low Incidence of Severe Mucositis After Myeloablative, HLA-Matched Bone Marrow Transplantation and High Dose, Post-Transplantation Cyclophosphamide
Wendy Ying ... Ephraim J Fuchs
Blood | VOL. 118
Wendy Ying, et. al.Wendy Ying ... Ephraim J Fuchs
18 Nov 2011
Effect of Concurrent Proton Pump Inhibitors With Palbociclib Tablets for Metastatic Breast Cancer
Timothy Schieber ... Craig Vargo
Clinical Breast Cancer | VOL. 23
Timothy Schieber, et. al.Timothy Schieber ... Craig Vargo
24 May 2023
Leucovorin Following Methotrexate Graft-Vs-Host Disease Prophylaxis in Myeloablative Allogeneic Hematopoietic Transplantation Shortens the Duration of Mucositis and Hospitalization
Craig W Freyer ... David L Porter
Blood | VOL. 132
Craig W Freyer, et. al.Craig W Freyer ... David L Porter
29 Nov 2018
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Social Determinants of Health and Access to Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia.
Natalie Wuliji ... Mohamed L Sorror
Blood | VOL. -
Natalie Wuliji, et. al.Natalie Wuliji ... Mohamed L Sorror
11 Mar 2025
Clonal Hematopoiesis Landscape in Frequent Blood Donors.
Darja Karpova ... Andreas Trumpp
Blood | VOL. -
Darja Karpova, et. al.Darja Karpova ... Andreas Trumpp
11 Mar 2025
Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study.
Guy Young ... Gili Kenet
Blood | VOL. -
Guy Young, et. al.Guy Young ... Gili Kenet
07 Mar 2025
Long-term outcomes with single-agent BRAF inhibitor therapy in Erdheim-Chester disease.
Gaurav Goyal ... Eli L Diamond
Blood | VOL. -
Gaurav Goyal, et. al.Gaurav Goyal ... Eli L Diamond
07 Mar 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.